---
id: mucormycosis-dermatophytosis_335
category: organisms
tags: [mucormycosis, zygomycosis, Rhizopus, Mucor, dermatophytosis, tinea, angioinvasion, amphotericin-B, terbinafine]
deck: Infectious Diseases
created: 2025-01-11
modified: 2025-01-11
---

## Mucormycosis and Dermatophytosis

**Q:** What are the key features and treatments for mucormycosis and dermatophytosis?

**A:**

**Mucormycosis (Zygomycosis):**

**Organisms:**
- **Mucorales order**: *Rhizopus* (most common), *Mucor*, *Rhizomucor*, *Cunninghamella*
- Ubiquitous molds in environment (soil, decaying organic matter)

**Risk Factors:**
- **DKA** (most important; 40-50% of rhinocerebral cases)
- Immunosuppression: Neutropenia, hematologic malignancy, HSCT
- **Deferoxamine use** (iron chelator; provides iron to fungus)
- Corticosteroid therapy
- Solid organ transplant

**Clinical Syndromes:**

| Syndrome | Frequency | Clinical Features | Risk Factors |
|----------|-----------|------------------|--------------|
| **Rhinocerebral** | **Most common** (40-50%) | **Black necrotic eschar** on palate/nasal turbinates; facial pain, proptosis, ophthalmoplegia; **orbital/brain invasion** | **DKA**, diabetes mellitus |
| **Pulmonary** | 20-30% | Fever, cough, hemoptysis, dyspnea; cavitation on imaging | Neutropenia, HSCT, hematologic malignancy |
| **Cutaneous** | 10-20% | Necrotic eschar at wound site; rapid spread | Burns, trauma, surgery |
| **Disseminated** | 5-10% | Multiorgan involvement; high mortality | Severe immunosuppression |
| **Gastrointestinal** | Rare | Abdominal pain, GI bleeding, perforation | Malnutrition, prematurity |

**Hallmark Feature: ANGIOINVASION**
- Invades blood vessels → **thrombosis**, **tissue necrosis**, **infarction**
- Black necrotic eschar (devitalized tissue from vascular occlusion)
- Dissemination via hematogenous spread

**Diagnosis:**
- **Tissue biopsy** (gold standard): Broad (5-20 μm), ribbon-like, **non-septate** hyphae with **90° angle branching** (vs *Aspergillus*: septate, acute angle branching)
- **Culture**: May be negative (low yield); requires tissue
- **Imaging**: CT/MRI shows sinus opacification, bone erosion, orbital/intracranial extension

**Treatment:**

| Component | Details | Notes |
|-----------|---------|-------|
| **Antifungal** | **Liposomal amphotericin B 5-10 mg/kg IV daily** (first-line) | Start ASAP; delay = worse outcomes |
| | **Alternatives**: Isavuconazonium, posaconazole (salvage or step-down) | Azoles less effective as monotherapy |
| **Surgery** | **Aggressive surgical debridement** (repeated as needed) | **Critical**; debridement + antifungals superior to antifungals alone |
| **Reversal of risk factors** | Correct DKA, hyperglycemia, discontinue deferoxamine, reduce immunosuppression | Essential for cure |
| **Duration** | Weeks-months (until clinical/radiologic resolution) | Monitor closely; high relapse risk |

**Key Points:**
- **Mucormycosis = DKA + black necrotic eschar** (rhinocerebral)
- **Angioinvasion** → thrombosis, necrosis, infarction
- **Treatment**: Liposomal amphotericin B + **aggressive surgical debridement** (both required)
- High mortality (50-80% rhinocerebral if untreated; 20-40% with optimal treatment)

---

**Dermatophytosis (Tinea):**

**Organisms:**
- ***Trichophyton*** (most common: *T. rubrum, T. mentagrophytes, T. tonsurans*)
- ***Microsporum*** (*M. canis* - zoophilic; pets)
- ***Epidermophyton*** (*E. floccosum*)

**Clinical Types:**

| Type | Location | Clinical Features | Treatment |
|------|----------|------------------|-----------|
| **Tinea capitis** | **Scalp** | Scaly patches with alopecia; **kerion** (boggy, purulent mass); cervical lymphadenopathy | **Systemic**: Griseofulvin OR terbinafine × 6-12 weeks |
| **Tinea corporis** | Body (trunk, extremities) | **Annular plaques** with raised scaly border, central clearing ("ringworm") | **Topical**: Azoles (clotrimazole, miconazole), terbinafine × 2-4 weeks |
| **Tinea cruris** | Groin ("jock itch") | Pruritic, erythematous plaques in inguinal folds (spares scrotum) | **Topical**: Azoles, terbinafine × 2-4 weeks |
| **Tinea pedis** | Feet ("athlete's foot") | Interdigital scaling/maceration; moccasin distribution (soles); vesicular | **Topical**: Azoles, terbinafine × 2-4 weeks; systemic if refractory |
| **Tinea unguium** (onychomycosis) | Nails | Thickened, discolored, brittle nails; subungual debris | **Systemic**: Terbinafine 250 mg PO daily × 12 weeks (toenails), 6 weeks (fingernails) |

**Diagnosis:**
- **KOH prep**: Septate branching hyphae
- **Culture**: Sabouraud agar (slow-growing; 2-4 weeks)
- **Wood's lamp**: *Microsporum* fluoresces green (not *Trichophyton*)

**Treatment:**

| Severity | First-Line | Notes |
|----------|-----------|-------|
| **Localized (corporis, cruris, pedis)** | **Topical azoles** (clotrimazole, miconazole) OR **terbinafine 1% cream** × 2-4 weeks | BID application |
| **Tinea capitis** (always systemic) | **Terbinafine 250 mg PO daily** OR **griseofulvin 500 mg PO daily** × 6-12 weeks | Topical alone ineffective (hair shaft involved) |
| **Tinea unguium (onychomycosis)** | **Terbinafine 250 mg PO daily** × 12 weeks (toenails), 6 weeks (fingernails) | Most effective; cure rate 70-80% |
| | **Alternative**: Itraconazole pulse therapy (200 mg BID × 1 week/month × 2-3 pulses) | |
| **Extensive/refractory** | **Systemic terbinafine** or itraconazole | |

**Key Points:**
- **Tinea capitis**: Only dermatophytosis requiring systemic therapy (hair shaft invasion)
- **Tinea unguium**: Terbinafine 250 mg daily × 12 weeks (toenails)
- **Topical therapy**: Sufficient for corporis, cruris, pedis (localized)
- **Wood's lamp**: Microsporum fluoresces (green); Trichophyton does not

**Mnemonic - "Mucor Munches vessels (angioinvasion), Tinea = Topical for skin, Terbinafine for scalp/nails"**

**Pearl:** Mucormycosis requires liposomal amphotericin B + aggressive surgical debridement (both critical). DKA most important risk factor; presents with black necrotic eschar (rhinocerebral). Angioinvasion → thrombosis, necrosis. Dermatophytosis: topical azoles/terbinafine for skin (corporis, cruris, pedis); systemic terbinafine for scalp (tinea capitis) and nails (onychomycosis). Tinea capitis requires systemic therapy (hair shaft involvement).

**Media:**

**Sources:** [StatPearls Mucormycosis NBK544364], [CDC Fungal Mucormycosis], [StatPearls Tinea Infections], [IDSA Dermatophyte Guidelines]
